Pressure BioSciences, Inc., a life sciences company, engages in the research, development, and commercialization of pressure cycling technology (PCT) that uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. The company offers Barocycler instrumentation, which includes Barocycler NEP3229 that is capable of processing up to three samples si...
Today Pressure BioSciences Incorporated announced that it has added a new member to its senior executive management team; Vice President of Sales. Matthew B. Potter will now oversee Pressure Biosciences’ seven US-based, regional sales directors and will be responsible for driving the Company’s commercialization of their novel and patented pressure cycling technology (PCT) product line. ...
Founded in 1978, Pressure Biosciences (NASDAQ: PBIO) began significant operations in 1986 and went public 10 years later in 1996, under its former name, Boston Biomedica, Inc. Today the company holds 13 U.S. patents and four foreign patents for applications of its Pressure Cycling Technology (PCT), used in the healthcare field for genomics, proteomics and nucleic acid testing with the ability to ru...
QualityStocks.net Featured Companies
- In this discussion we will present articles highlighting the companies we are currently featuring and believe to have the potential to grow rapidly in
About Pressure BioSciences Inc.
- Answers.com
